Therapeutic effect of the umbilical blood stem cell transplantation on the treatment of hepatitis B liver cirrhosis
10.3969/j.issn.1006-5725.2015.19.014
- VernacularTitle:脐血干细胞移植治疗乙型肝炎肝硬化的疗效
- Author:
Sui ZHANG
;
Baoyong YAN
;
Lixin TONG
;
Lihong GUO
;
Wei DUAN
;
Dawei YANG
;
Lixia ZHANG
- Publication Type:Journal Article
- Keywords:
Human umbilical cord blood stem cell transplantation;
Hepatitis B liver cirrhosis;
Therapy
- From:
The Journal of Practical Medicine
2015;(19):3162-3165
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of umbilical blood stem cell transplantation (UCBSCT) on the treatment of hepatitis B liver cirrhosis. Methods Forty-eight patients with hepatitis B liver cirrhosis were enrolled and divided into the treatment group and the control group. There were 25 patients in the treatment group , who received UCBSCT treatment based on conventional liver protection treatment and 23 patients in the control group , who received conventional liver protection treatment. The changes of liver function , coagulation function, clinical symptoms, signs and side effects were studied before the treatment and at 2, 4, 12 and 24 weeks post-treatment. Results The levels of albumin, cholinesterase, and prothrombin activity in the treatment group were higher than those before treatment and were higher than those in the control group. The parameters in the control group were not significantly changed before and after the treatment (P > 0.05). The levels of alanine aminotransferase,aspartate aminotransferase,total bilirubin in both two groups were not significantly changed before and after the treatment (P > 0.05). After 4-week treatment,the differences on improvement of appetite , lacking in strength , abdominal distension , ascites were statistically significant in the treatment group compared with the control group (P < 0.05). No adverse reactions were observed in all groups. Conclusion UCBSCT on the treatment of hepatitis B liver cirrhosis is safe and reliable.
